Related Experiment Video
Updated: Oct 11, 2025

04:33
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
867
[Reducing depressive symptoms in patients with dementia]
1Parnassia Groep, Den Haag.
Nederlands Tijdschrift Voor Geneeskunde
|December 2, 2021
Summary
This comment reviews a meta-analysis on depression in dementia. Psychosocial interventions, not medications, were most effective for reducing depressive symptoms in dementia patients.
Area of Science:
- Gerontology
- Psychiatry
- Clinical Medicine
Background:
- Depressive symptoms are common in individuals with dementia.
- Effective interventions for managing depression in this population are crucial.
- Previous reviews have synthesized evidence on various treatment approaches.
Purpose of the Study:
- To critically evaluate a network meta-analysis (NMA) comparing interventions for depressive symptoms in dementia.
- To assess the efficacy of different treatments beyond standard care.
- To identify the most effective interventions based on available evidence.
Main Methods:
- The comment reflects on a systematic review and NMA including 256 randomized controlled trials (RCTs).
- Analysis focused on interventions compared to treatment as usual for depressive symptoms in dementia.
- Limitations regarding the scope of included RCTs and data presentation were noted.
Main Results:
- Only 10 interventions demonstrated greater efficacy than treatment as usual.
- Most effective interventions were psychosocial treatments.
- Acetylcholinesterase inhibitors combined with cognitive stimulation showed superiority over treatment as usual.
Conclusions:
- Psychosocial interventions are key for managing depressive symptoms in dementia patients.
- The NMA provides guidance on selecting optimal psychosocial interventions.
- Further research is needed, particularly for patients with diagnosed depressive disorders.
Related Concept Videos
Depressive Disorders: MDD and Dysthymia
236
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
236
Alzheimer's Disease: Treatment
290
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
290
Dementia
213
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
213
Antidepressant Drugs: MAOIs and Other Agents
420
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
420
Depression: Overview
424
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
424
Negative and Cognitive Symptoms of Schizophrenia
141
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
141

